Glyconiazide

• CAT Number: I028141
• CAS Number: 3691-74-5
• Molecular Formula: C12H13N3O6
• Molecular Weight: 295.25
• Purity: 98%
• Synonyms: D(+)-Glucose isonicotinoyl hydrazone; Galatone; Glucazide; Glyconiazide; INH-G
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: N-[(E)-[(2S)-2-[(2R,3R,4S)-3,4-dihydroxy-5-oxooxolan-2-yl]-2-hydroxyethylidene]amino]pyridine-4-carboxamide
• InChI: InChI=1S/C12H13N3O6/c16-7(10-8(17)9(18)12(20)21-10)5-14-15-11(19)6-1-3-13-4-2-6/h1-5,7-10,16-18H,(H,15,19)/b14-5+/t7-,8+,9-,10+/m0/s1
• InChIKey: ZBRCAASZBMWIDA-QFPUCQTMSA-N
• SMILES: C1=CN=CC=C1C(=O)N/N=C/[C@@H]([C@@H]2[C@@H]([C@@H](C(=O)O2)O)O)O

Glyconiazide（Cat No.:I028141）is an oral antidiabetic medication used to manage type 2 diabetes. It belongs to the sulfonylurea class of drugs, which work by stimulating the pancreas to release more insulin, thus lowering blood sugar levels. Glyconiazide also improves insulin sensitivity in peripheral tissues. It is typically prescribed alongside lifestyle changes, including diet and exercise, to help control blood glucose. As with other sulfonylureas, the main side effects include the risk of hypoglycemia and weight gain. Ongoing research explores its effectiveness, safety profile, and potential use in combination with other diabetic treatments.